XML 89 R38.htm IDEA: XBRL DOCUMENT v2.4.0.6
Other Current Assets (Detail) (USD $)
In Thousands, unless otherwise specified
Dec. 31, 2011
Dec. 31, 2010
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Line Items]    
Research and development credits receivable   $ 351 [1]
Prepaid expenses and other 1,837 712
Other current assets $ 1,837 $ 1,063
[1] Represents refunds receivable in the U.K. for research and development expenditures incurred in 2009 at Amarin Neuroscience Ltd (ANL).